Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis
- PMID: 32596355
- PMCID: PMC7294360
- DOI: 10.1155/2020/6942740
Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis
Abstract
Objective: To explore the expression of immune-related lncRNAs in colon adenocarcinoma and find out the effect on how these lncRNAs influence the development and prognosis of colon adenocarcinoma.
Method: Transcriptome data of colon adenocarcinoma from The Cancer Genome Atlas (TCGA) were downloaded, and gene sets "IMMUNE RESPONSE" and "IMMUNE SYSTEM PROCESS" were sought from the Molecular Signatures Database (MSigDB). The expression of immune-related genes was extracted that were immune-related mRNAs. Then, the immune-related lncRNAs were sought out by utilizing of the above data. Clinical traits were combined with immune-related lncRNAs, so that prognostic-related lncRNAs were identified by Cox regression. Multivariate Cox regression was built to calculate risk scores. Relationships between clinical traits and immune-related lncRNAs were also calculated.
Result: A total of 480 colorectal adenocarcinoma patients and 41 normal control patients' transcriptome sequencing data of tissue samples were obtained from TCGA database. 918 immune-related lncRNAs were screened. Cox regression showed that 34 immune-related lncRNAs were associated with colon adenocarcinoma prognosis. Seven lncRNAs were independent risk factors.
Conclusion: This study revealed that some lncRNAs can affect the development and prognosis of colon adenocarcinoma. It may provide new theory evidence of molecular mechanism for the future research and molecular targeted therapy of colon adenocarcinoma.
Copyright © 2020 Meiwei Mu et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.Biomed Res Int. 2020 Sep 2;2020:9807918. doi: 10.1155/2020/9807918. eCollection 2020. Biomed Res Int. 2020. PMID: 32964050 Free PMC article.
-
Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.J Cell Biochem. 2019 Mar;120(3):4121-4131. doi: 10.1002/jcb.27697. Epub 2018 Sep 30. J Cell Biochem. 2019. PMID: 30269368
-
Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.Dis Markers. 2022 Sep 17;2022:4492608. doi: 10.1155/2022/4492608. eCollection 2022. Dis Markers. 2022. PMID: 36168326 Free PMC article.
-
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.Oncol Rep. 2018 May;39(5):2365-2375. doi: 10.3892/or.2018.6324. Epub 2018 Mar 19. Oncol Rep. 2018. PMID: 29565464
-
Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.Cell Physiol Biochem. 2018;49(5):1778-1791. doi: 10.1159/000493623. Epub 2018 Sep 19. Cell Physiol Biochem. 2018. PMID: 30231249
Cited by
-
A risk model constructed using 14 N6-methyladenosine-related lncRNAs as a new prognostic marker that correlates with the immunomodulatory effect and drug sensitivity in colorectal cancer.J Gastrointest Oncol. 2023 Jun 30;14(3):1360-1377. doi: 10.21037/jgo-23-412. J Gastrointest Oncol. 2023. PMID: 37435206 Free PMC article.
-
Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma.Front Cell Dev Biol. 2021 Feb 25;9:625212. doi: 10.3389/fcell.2021.625212. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33732694 Free PMC article.
-
Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.Front Genet. 2021 Sep 6;12:690530. doi: 10.3389/fgene.2021.690530. eCollection 2021. Front Genet. 2021. PMID: 34552614 Free PMC article.
-
Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.Mol Med. 2021 Aug 3;27(1):83. doi: 10.1186/s10020-021-00343-x. Mol Med. 2021. PMID: 34344319 Free PMC article.
-
Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.Front Oncol. 2021 Aug 11;11:704038. doi: 10.3389/fonc.2021.704038. eCollection 2021. Front Oncol. 2021. PMID: 34458145 Free PMC article.
References
-
- Hanisch C., Sharbati J., Kutz-Lohroff B., Huber O., Einspanier R., Sharbati S. TFF3-dependent resistance of human colorectal adenocarcinoma cells HT-29/B6 to apoptosis is mediated by miR-491-5p regulation of lncRNA PRINS. Cell Death Discovery. 2017;3(1):p. 16106. doi: 10.1038/cddiscovery.2016.106. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources